Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 21, 2013

View Archived Issues

Jazz Pharmaceuticals presents company outlook

Discovery of novel dual NK1 receptor antagonist/SERT inhibitor for the treatment of depression

International Stem Cell tests its hpSC-derived hepatocytes in vivo

Bosutinib receives positive CHMP opinion for conditional marketing authorization

CHMP recommends approval of Jetrea in Europe for vitreomacular traction

Novel antibacterials created by Kyorin and Merck & Co.

YH-GKA identified as a novel glucokinase activator for treating diabetes

New HDAC6 inhibitors designed at U.S. institutes

Researchers design a gene knockout mouse using TALEN-mediated mutagenesis in zygotes

State University of New Jersey patents novel RNA polymerase bipartite inhibitors

Research at Myrexis yields new NAmPRTase inhibitors

Research at Roche and Genentech disclose novel PC9-binding peptides

University of Pittsburgh designs novel H1N1 influenza vaccines

Serina Therapeutics partners with AstraZeneca

Cancer Research UK and AstraZeneca begin clinical development of AZD-0424

Hexal presents new prodrugs of cilazapril

FDA approves Botox for overactive bladder

EMA confirms recommendation to suspend nicotinic acid/laropiprant

Roche presents new HCV therapeutics

Recordati completes acquisition of certain Lundbeck products

Phase II trial of ponatinib in squamous cell lung cancer begins

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...